Grassley Expands FDA Drug Safety Inquiry
Senate Finance Committee Chairman Chuck Grassley (R-Iowa) has requested that the General Accounting Office review the relationship between FDA's Office of Drug Safety and Office of New Drugs
Senate Finance Committee Chairman Chuck Grassley (R-Iowa) has requested that the General Accounting Office review the relationship between FDA's Office of Drug Safety and Office of New Drugs